Skip to content

Addiction: all studies

Page 759 of 860: studies 7,581 to 7,590 of 8,594, newest first. Back to the addiction overview

Research

Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.

Journal of Pharmacology and Experimental Therapeutics June 2007 Pablo R Moya, Kelly A Berg, Manuel A Gutiérrez-Hernandez et al.

2,5-Dimethoxy-4-substituted phenylisopropylamines and phenethylamines are 5-hydroxytryptamine (serotonin) (5-HT)(2A/2C) agonists. The former are partial to full agonists, whereas the latter are partial to weak agonists. However, most data come from studies analyzing phospholipase C (PLC)-mediated responses, although additional effectors [e.g., phospholipase A(2) (PLA(2))] are associated with...

PTSD symptoms, substance use, and vipassana meditation among incarcerated individuals.

Journal of Traumatic Stress June 1, 2007 Tracy L. Simpson, D Kaysen, Sarah Bowen et al.

The present study evaluated whether Posttraumatic Stress Disorder (PTSD) symptom severity was associated with participation and treatment outcomes comparing a Vipassana meditation course to treatment as usual in an incarcerated sample. This study utilizes secondary data. The original study demonstrated that Vipassana meditation is associated with reductions in substance use. The present study...

Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.

European Journal of Pharmacology May 21, 2007 Beatriz Goñi-allo, Elena Puerta, Isabel Hervias et al. 13 citations

Amiloride and several of its congeners known to block the Na(+)/Ca(2+) and/or Na(+)/H(+) antiporters potentiate methamphetamine-induced neurotoxicity without altering methamphetamine-induced hyperthermia. We now examine whether amiloride also exacerbates 3,4-methylenedioxymethamphetamine (MDMA)-induced long-term serotonin (5-HT) loss in rats. Amiloride (2.5 mg/kg, every 2 h x 3, i.p.) given at...

Anthropology of consciousness

Cambridge University Press eBooks May 14, 2007 C. Jason Throop, Charles D. Laughlin 26 citations

Empirical evidence shows that much of the functioning of our motor system occurs without awareness. It seems that consciousness can manifest itself at three stages: intention to perform an action, performance of intended action, and perception of the effects of performed action. This chapter reviews the evidence that suggests that many aspects of action, from initiation to appreciation of the...

Acute activation of CB1 cannabinoid receptors transiently decreases PSA-NCAM expression in the dentate gyrus of the rat hippocampus.

Brain Research May 7, 2007 Marzena Maćkowiak, Agnieszka Chocyk, Katarzyna Markowicz-Kula et al.

Recent evidence indicates that the polysialylated neural cell adhesion molecule (PSA-NCAM) is involved in hippocampal plasticity. On the other hand, CB1 receptor activation is known to disturb some hippocampal processes involving plastic changes, such as learning and memory. Therefore, the present study investigated the effect of HU-210, a CB1 receptor agonist, on the expression of PSA-NCAM...

Mental Training Affects Distribution of Limited Brain Resources

PLoS Biology May 4, 2007 Heleen A. Slagter, Antoine Lutz, Lawrence L. Greischar et al. 762 citations

The information processing capacity of the human mind is limited, as is evidenced by the so-called "attentional-blink" deficit: When two targets (T1 and T2) embedded in a rapid stream of events are presented in close temporal proximity, the second target is often not seen. This deficit is believed to result from competition between the two targets for limited attentional resources. Here we...

DOI: 10.1371/journal.pbio.0050138 (opens in new tab) Attentional blink Cognitive psychology Task project management Attentional control +4

The role of caspase-3 activation in phencyclidine-induced neuronal death in postnatal rats.

Neuropsychopharmacology May 2007 Cheng Z Wang, Kenneth M Johnson

This study determined the role of caspase-3 in phencyclidine (PCP)-induced neurodegeneration in postnatal rats. PCP administration to postnatal day 7 rats induced a dose-dependent increase in caspase-3 enzymatic activity in frontal cortex, striatum, and hippocampus. Enzymatic activation was present at 4 h, peaked between 6 and 12 h, and disappeared by 24 h. Further, cleaved...

The relationship between non‐acute adolescent cannabis use and cognition

Drug and Alcohol Review May 1, 2007 Megan A. Harvey, John D. Sellman, Richard Porter et al.

AbstractResearch indicates that cannabis continues to be a popular illegal drug internationally. Furthermore, adolescent rates of use appear to be significant. Whilst the non‐acute effect of cannabis use on adult cognition has been extensively researched, there has been less examination of adolescents. This study aimed to investigate the non‐acute relationship between cannabis and cognitive...

Intravenous ketamine therapy in a patient with a treatment-resistant major depression

Swiss Medical Weekly April 21, 2007 Michael Liebrenz, Alain Borgeat, R Leisinger 75 citations

BACKGROUND: Recently, reports from North America have indicated that the intravenous infusion of ketamine hydrochloride (an N-methyl-d-aspartate receptor antagonist) results in a sudden and robust improvement of depression symptoms. OBJECTIVE: To corroborate antidepressant effectiveness of IV ketamine in a patient with a co-occurring substance use disorder for the first time in a European...

Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.

Cochrane Database of Systematic Reviews April 18, 2007 M A Gillman, F J Lichtigfeld, T N Young

Alcoholism is a global problem with 5-10% of the world's population demonstrating alcohol-related diseases. One of the most severe consequences of alcohol dependence is the withdrawal syndrome, for which benzodiazepines are the most popular current treatment. An alternative method to benzodiazepine employs psychotropic analgesic nitrous oxide (PAN). To assess the effects of PAN for treating...